Late Breaking Abstract - The Role of the chemokine receptor CCR3 in House Dust Mite (HDM) induced experimental asthma

S. Krammer (Erlangen, Germany), N. Li (Erlangen, Germany), Z. Yang (Erlangen, Germany), J. Koelle (Erlangen, Germany), C. Geppert (Erlangen, Germany), R. Rieker (Erlangen, Germany), G. Graham (Glasgow, United Kingdom), S. Finotto (Erlangen, Germany)

Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Session: New insight into the immunology of asthma and COPD
Session type: E-poster session
Number: 306
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Krammer (Erlangen, Germany), N. Li (Erlangen, Germany), Z. Yang (Erlangen, Germany), J. Koelle (Erlangen, Germany), C. Geppert (Erlangen, Germany), R. Rieker (Erlangen, Germany), G. Graham (Glasgow, United Kingdom), S. Finotto (Erlangen, Germany). Late Breaking Abstract - The Role of the chemokine receptor CCR3 in House Dust Mite (HDM) induced experimental asthma. 306

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract: Interferon response factor-3 is required for airway allergy to house dust mite in mice
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Resolvin E3 attenuates House Dust Mite (HDM) -induced asthmatic inflammation in a murine model
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Beta2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation in mice
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014


Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Late Breaking Abstract - Budget impact of introducing 12SQ HDM SLIT-tablet for house dust mite allergic asthma in Spain
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019

Late Breaking Abstract - Link between IL-22 and IL-10, IL-13, and severity of symptoms in patients with allergic airway diseases caused by house dust mite
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020


LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

LSC 2010 Abstract: Role of HIF-1α on airway remodelling induced by house dust mite
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

LSC 2014 abstract - Influenza-induced exacerbation in a murine chronic house dust mite (HDM) asthma model
Source: International Congress 2014 – Exploring molecular mechanisms of allergy and asthma in animal models
Year: 2014

Ration of IL1beta / IL1-receptor antagonist (RA) in alveolar macrophages of induced sputum of patients with asthma during long-term follow-up
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014


Oral presentation: Role of HIF-1? on airway remodelling induced by house dust mite
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010

Late-breaking abstract: House dust mite triggering of Dectin-2 is critical for the initiation of allergic airway inflammation
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Year: 2011

Time course of serum inhibitory activity for facilitated allergen-IgE binding during house dust mite immunotherapy
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Characterisation of lung-resident pericytes in a house dust mite-driven model of asthma
Source: International Congress 2015 – Airway remodelling: recent developments
Year: 2015


LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015



Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

Absence of proton sensing OGR1 protects against house dust mite-induced allergic airway inflammation
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016

LATE-BREAKING ABSTRACT: Attenuation of allergen-induced asthmatic responses by inhaled GATA-3 specific DNAzyme
Source: International Congress 2014 – Latest insights in airway diseases
Year: 2014

Hyperactivity of the IL33-ST2 axis during postnatal alveolarization increases susceptibility to house dust mite sensitization via skewing of CD11b+ dendritic cells
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014